Anika Therapeutics, Inc.
ANIK
$11.08
-$0.19-1.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.88M | -34.52M | -97.52M | -74.18M | -76.83M |
| Total Depreciation and Amortization | 5.84M | 6.31M | 9.88M | 11.24M | 12.73M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.68M | 42.76M | 108.44M | 83.26M | 82.75M |
| Change in Net Operating Assets | -6.82M | -10.73M | -13.34M | -11.39M | -16.94M |
| Cash from Operations | 3.82M | 3.82M | 7.46M | 8.93M | 1.70M |
| Capital Expenditure | -7.44M | -6.43M | -8.27M | -7.79M | -5.85M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.90M | -600.00K | -600.00K | -- | -- |
| Cash from Investing | -3.55M | -7.03M | -8.87M | -7.79M | -5.85M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 464.00K | 487.00K | 822.00K | 822.00K | 844.00K |
| Repurchase of Common Stock | -11.00M | -7.86M | -7.86M | -3.97M | -7.83M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.54M | -7.38M | -7.03M | -3.15M | -6.98M |
| Foreign Exchange rate Adjustments | 221.00K | 82.00K | 158.00K | -233.00K | 18.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.05M | -10.50M | -8.28M | -2.25M | -11.11M |